DVAX 13F Hedge Fund and Asset Management Owners

Data as of 2021-05-08 10:36:23 -0400
Market Cap	1.124 Billion	Shares Outstanding	114.588 Million	Avg 30-day Volume	2.654 Million
P/E Ratio	-14.94033	Dividend Yield		EPS	-0.741
Price/Sales	24.15	Debt to Equity	6.02	EBITDA	-68.387 Million
Price to Book Value	19.15	Forward PE	16.7	Enterprise Value	1.139 Billion
Total Cash	165.036 Million	Current Debt	77.411 Million	Gross Profit	32.641 Million
BETA	1.39945	52-week High/Low	12.44 / 3.55	Next Earnings Date	2021-08-05	Price to Cash FLow (P/CF)	-9999999.0
				Data provided by IEX Cloud

Q4 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	2	2	0.0%	1 (0.06%)	1 (0.06%)	0.0%
Funds Holding:	142	163	-12.88%	32 (1.92%)	46 (2.86%)	-30.43%
13F shares:	84.103 Million	88.06 Million	-4.49%	14.161 Million	19.627 Million	-27.85%
% Ownership	76.3369	79.9294	-4.49%	12.8536	17.8145	-27.85%
New Positions:	11	43	-74.42%	4	18	-77.78%
Increased Positions	53	49	8.16%	10	12	-16.67%
Closed Positions	31	26	19.23%	18	15	20.0%
Reduced Positions	43	40	7.5%	14	12	16.67%
Total Calls	661.73 Thousand	1.052 Million	-37.07%	140.8 Thousand	300.4 Thousand	-53.13%
Total Puts	800.924 Thousand	857.767 Thousand	-6.63%	74.7 Thousand	92.5 Thousand	-19.24%
PUT/CALL Ratio	1.21	0.82	47.56%	0.53	0.31	70.97%
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding DVAX (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DVAX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

20 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
NOVACK DAVID F PRESIDENT & COO	Officer	117,399	2021-04-01	2
JANSSEN ROBERT SENIOR VICE PRESIDENT	Officer	86,861	2021-03-12	5
MACDONALD KELLY SVP AND CFO	Officer	0	2021-03-01	2
BURGESS JUSTIN PRINCIPAL ACCOUNTING OFFICER	Officer	33,718	2021-02-26	3
SPENCER RYAN CEO AND DIRECTOR	Officer Director	90,453	2021-02-22	2
OSTRACH MICHAEL S SENIOR VICE PRESIDENT	Officer	0	2021-02-03	1
PARADISO PETER R.	Director	0	2020-09-23	2
EASTLAND JULIA MARIE	Director	0	2020-07-17	2
MACGREGOR BRENT	Director	0	2020-07-17	2
PHILLIPS PEGGY V	Director	0	2020-05-28	1
ORONSKY ARNOLD L	Director	0	2020-05-28	1
CANO FRANCIS	Director	0	2020-05-28	1
KISNER DANIEL L	Director	0	2020-05-28	1
RICCIARDI NATALE S	Director	0	2020-05-28	1
HACK ANDREW A. F.	Director	0	2020-05-28	2
JOHNSON DAVID LOUIS VICE PRESIDENT	Officer	48,380	2020-03-13	0
COFFMAN ROBERT SENIOR VICE PRESIDENT	Officer	77,768	2019-06-02	0
GRAY EDDIE CEO AND DIRECTOR	Officer Director	304,597	2019-06-02	0
CARSON DENNIS	Director	0	2019-05-30	0
BREGE LAURA	Director	0	2019-05-30	0
PLOTKIN STANLEY A	Director	0	2017-06-02	0
DINA DINO	Director	0	2014-05-28	0
GILBERT DENISE	Director	0	2014-05-28	0
LEW JENNIFER VP, FINANCE & PAO	Officer	0	2013-02-05	0
TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS	Officer	0	2013-02-05	0
MARTIN J TYLER PRESIDENT, CMO & DIRECTOR	Officer Director	222,089	2012-11-16	0
KESSEL MARK	Director	3,031,431	2012-10-16	0
LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER	Officer	0	2012-08-13	0
JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE	Officer	0	2012-03-09	0
BUC NANCY L	Director	0	2010-05-12	0
LAWRENCE DAVID M	Director	0	2010-05-12	0
SYMPHONY CAPITAL PARTNERS LP SYMPHONY CAPITAL GP, L.P. SYMPHONY GP, LLC SYMPHONY STRATEGIC PARTNERS LLC TARANTO HARRI V	Director 10% Owner SEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKSSEE FOOTNOTE 5 AND REMARKS	9,031,431	2010-04-16	0
BVF PARTNERS L P/IL BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC/IL	10% Owner DIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNER	17,115,404	2009-09-10	0
BVF PARTNERS L P/IL BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC/IL	10% Owner INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER	25,254,628	2009-06-03	0
SMELTZER DEBORAH A VP, OPERATIONS & CFO	Officer	0	2009-03-10	0
FLYNN JAMES E DEERFIELD CAPITAL LP DEERFIELD SPECIAL SITUATIONS FUND, L.P. DEERFIELD MANAGEMENT CO /NY DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD DEERFIELD PRIVATE DESIGAN FUND L P DEERFIELD PRIVATE DESIGN INTERNATIONAL, L.P.	10% Owner	No longer subject to file	2008-10-22	0
SANDERS MARTIN E EVP AND CDO	Officer	0	2008-10-03	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Perf 1m*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
NOVACK DAVID F - Officer PRESIDENT & COO	2021-04-02 18:00:55 -0400	2021-04-01	S	20,000	$9.92	d	117,399	direct		2.8455	2.3374		2.8455	2	0.0	1

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security	Date/Time	Rebate Rate	Fee Rate	Shares Available

Current Active Short Positions

Holder	Issuer	Net Short Position	Position Date	Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund	DVAX	-10953.0 shares, $-40854.69	2020-10-31	N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund	DVAX	-1540.0 shares, $-6853.0	2020-12-31	N-PORT
LoCorr Investment Trust- LoCorr Dynamic Equity Fund	DVAX	-4009.0 shares, $-17840.05	2020-12-31	N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund	DVAX	-30.0 shares, $-294.9	2021-03-31	N-PORT

Dynavax Technologies Corp YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Dynavax Technologies Corp (DVAX)

WhaleWisdom Alpha

Our Other Reporting & Analysis